Thymopoietin II (32-36)-ethyl ester is a short thymopoietin fragment chemically modified at the C-terminus. Esterification adjusts hydrophobicity and may influence membrane interaction and uptake. Core sequence retains turn-forming propensity. The peptide serves as a tool to study prodrug-like modifications and short immunoregulatory motifs.
CAT No: T07009
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More